Transforming growth factor beta I and sodium butyrate differentially modulate urokinase plasminogen activator and plasminogen activator inhibitor-I in human breast normal and cancer cells
1998

Effects of TGF-beta and Sodium Butyrate on Breast Cells

publication Evidence: moderate

Author Information

Author(s): X Dong-Le Bourhis, V Lambrecht, B Boilly

Primary Institution: Unite Dynamique des Cellules Embryonnaires et Cancereuses, Centre de Biologie Cellulaire, Universite des Sciences et Technologies de Lille

Hypothesis

How do TGF-beta and sodium butyrate affect cell proliferation and the urokinase plasminogen activator system in breast cells?

Conclusion

TGF-beta inhibits cell proliferation and uPA activity in normal breast cells but promotes invasion in cancer cells, while sodium butyrate inhibits both cell proliferation and uPA activity.

Supporting Evidence

  • TGF-beta inhibited cell proliferation and uPA activity in normal breast cells.
  • Sodium butyrate inhibited both cell proliferation and uPA activity in both normal and cancer cells.
  • TGF-beta increased PAI-1 levels in cancer cells, which may promote invasion.

Takeaway

This study found that a substance called TGF-beta can stop normal breast cells from growing but can help cancer cells invade more, while another substance, sodium butyrate, can help stop both normal and cancer cells from growing.

Methodology

The study compared the effects of TGF-beta and sodium butyrate on cell proliferation, uPA activity, and PAI-1 levels in normal human breast epithelial cells and a breast cancer cell line.

Participant Demographics

Normal human breast epithelial cells and breast cancer cell line MDA-MB-231 were used.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication